Humana Inc.
HUM | NYSE
$414.50
-$2.18 (-0.52%)
At close: Oct 30, 2026, 4:00 PM ET
$415.00
+$0.50 (+0.12%)
Pre-market:
Nov 2, 2026, 4:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 129.66B | 117.81B | 106.44B | 92.92B | 83.65B | 77.19B |
Cost of Revenue | 110.81B | 100.66B | 88.39B | 75.69B | 69.2B | 61.5B |
Gross Profit | 18.85B | 17.15B | 18.05B | 17.23B | 14.45B | 15.69B |
Operating Income | 1.45B | 1.63B | 3.32B | 3.56B | 3.42B | 4.67B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.45B | 1.63B | 3.32B | 3.56B | 3.42B | 4.67B |
Net Income | 1.19B | 1.21B | 2.49B | 2.81B | 2.93B | 3.37B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 17.4B | 15.52B | 14.73B | 13.67B | 11.03B | 11.02B |
Operating Expenses | 17.4B | 15.52B | 14.73B | 13.67B | 11.03B | 11.02B |
Interest Expense | 631M | 660M | 493M | 401M | 326M | 283M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 128.21B | 116.18B | 103.12B | 89.36B | 80.23B | 72.52B |
Income Tax Expense | 250M | 413M | 836M | 762M | 485M | 1.31B |
Shares Outstanding (Basic) | 120.45M | 120.57M | 123.87M | 126.42M | 128.69M | 132.2M |
Shares Outstanding (Diluted) | 120.83M | 120.87M | 124.44M | 127.09M | 129.4M | 133.01M |
EPS (Basic) | 9.87 | 10.01 | 20.09 | 22.20 | 22.79 | 25.47 |
EPS (Diluted) | 9.84 | 9.98 | 20 | 22.08 | 22.67 | 25.31 |
EBITDA | 2.91B | 3.26B | 4.73B | 4.81B | 4.46B | 5.57B |
EBIT | 2.08B | 2.29B | 3.81B | 3.97B | 3.75B | 4.96B |
Depreciation & Amortization | 824M | 968M | 917M | 845M | 713M | 616M |
Add to Watchlist
Select watchlists to add or remove HUM